Inhibitor scaffold for the histone lysine demethylase KDM4C (JMJD2C)

Research output: Contribution to journalJournal articleResearchpeer-review

The human histone demethylases of the KDM4 (JMJD2) family have been associated to diseases such as prostate and breast cancer, as well as X-linked mental retardation. Therefore, these enzymes are considered oncogenes and their selective inhibition might be a possible therapeutic approach to treat cancer. Here we describe a heterocyclic ring system library screened against the histone demethylase KDM4C (JMJD2C) in the search for novel inhibitory scaffolds. A 4-hydroxypyrazole scaffold was identified as an inhibitor of KDM4C; this scaffold could be employed in the further development of novel therapeutics, as well as for the elucidation of the biological roles of KDM4C on epigenetic regulation.
Original languageEnglish
JournalBioorganic & Medicinal Chemistry Letters
Issue number18
Pages (from-to)5811-3
Number of pages3
Publication statusPublished - 15 Sep 2012

    Research areas

  • Dose-Response Relationship, Drug, Drug Design, Enzyme Inhibitors, Humans, Jumonji Domain-Containing Histone Demethylases, Molecular Structure, Pyrazoles, Small Molecule Libraries, Structure-Activity Relationship

ID: 45967576